Literature DB >> 16098678

Control of colorectal metastasis formation by K-Ras.

Niels Smakman1, Inne H M Borel Rinkes, Emile E Voest, Onno Kranenburg.   

Abstract

Mutational activation of the K-Ras proto-oncogene is frequently observed during the very early stages of colorectal cancer (CRC) development. The mutant alleles are preserved during the progression from pre-malignant lesions to invasive carcinomas and distant metastases. Activated K-Ras may therefore not only promote tumor initiation, but also tumor progression and metastasis formation. Metastasis formation is a very complex and inefficient process: Tumor cells have to disseminate from the primary tumor, invade the local stroma to gain access to the vasculature (intravasation), survive in the hostile environment of the circulation and the distant microvascular beds, gain access to the distant parenchyma (extravasation) and survive and grow out in this new environment. In this review, we discuss the potential influence of mutant K-Ras on each of these phases. Furthermore, we have evaluated the clinical evidence that suggests a role for K-Ras in the formation of colorectal metastases.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16098678     DOI: 10.1016/j.bbcan.2005.07.001

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  24 in total

1.  Network analysis of microRNAs and genes in human osteosarcoma.

Authors:  Tianyan Wang; Zhiwen Xu; Kunhao Wang; Ning Wang
Journal:  Exp Ther Med       Date:  2015-08-17       Impact factor: 2.447

2.  Targeting the ERK pathway reduces liver metastasis of Smad4-inactivated colorectal cancer.

Authors:  Xi Ai; Yanhui Wu; Wei Zhang; Zhanguo Zhang; Guannan Jin; Jianping Zhao; Jingjing Yu; Youzhi Lin; Wanguang Zhang; Huifang Liang; Pran K Datta; Mingzhi Zhang; Bixiang Zhang; Xiaoping Chen
Journal:  Cancer Biol Ther       Date:  2013-09-12       Impact factor: 4.742

3.  Ras Signaling in Breast Cancer.

Authors:  Aree Moon
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

4.  The transcription factor HOXB7 regulates ERK kinase activity and thereby stimulates the motility and invasiveness of pancreatic cancer cells.

Authors:  Makiko Tsuboi; Keisuke Taniuchi; Takahiro Shimizu; Motoaki Saito; Toshiji Saibara
Journal:  J Biol Chem       Date:  2017-09-14       Impact factor: 5.157

5.  Differential colorectal carcinogenesis: Molecular basis and clinical relevance.

Authors:  Alberto Morán; Paloma Ortega; Carmen de Juan; Tamara Fernández-Marcelo; Cristina Frías; Andrés Sánchez-Pernaute; Antonio José Torres; Eduardo Díaz-Rubio; Pilar Iniesta; Manuel Benito
Journal:  World J Gastrointest Oncol       Date:  2010-03-15

6.  Synergy between bacterial infection and genetic predisposition in intestinal dysplasia.

Authors:  Yiorgos Apidianakis; Chrysoula Pitsouli; Norbert Perrimon; Laurence Rahme
Journal:  Proc Natl Acad Sci U S A       Date:  2009-11-23       Impact factor: 11.205

7.  Caveolin-1 is a novel regulator of K-RAS-dependent migration in colon carcinogenesis.

Authors:  Upal K Basu Roy; Rebecca S Henkhaus; Fotios Loupakis; Chiara Cremolini; Eugene W Gerner; Natalia A Ignatenko
Journal:  Int J Cancer       Date:  2013-02-12       Impact factor: 7.396

8.  The usability of allele-specific PCR and reverse-hybridization assays for KRAS genotyping in Serbian colorectal cancer patients.

Authors:  Ksenija Brotto; Emina Malisic; Milena Cavic; Ana Krivokuca; Radmila Jankovic
Journal:  Dig Dis Sci       Date:  2012-10-31       Impact factor: 3.199

Review 9.  Oncolytic virotherapy: molecular targets in tumor-selective replication and carrier cell-mediated delivery of oncolytic viruses.

Authors:  Z Sheng Guo; Stephen H Thorne; David L Bartlett
Journal:  Biochim Biophys Acta       Date:  2008-02-15

10.  Fast simultaneous detection of K-RAS mutations in colorectal cancer.

Authors:  Ya-Sian Chang; Kun-Tu Yeh; Tien-Jye Chang; Connie Chai; Hsiu-Chin Lu; Nicholas C Hsu; Jan-Gowth Chang
Journal:  BMC Cancer       Date:  2009-06-11       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.